PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 182 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $394,000 | -45.3% | 7,500 | -52.8% | 0.29% | +657.9% |
| Q4 2019 | $720,000 | -41.7% | 15,886 | -51.1% | 0.04% | -41.5% |
| Q3 2019 | $1,236,000 | -6.2% | 32,475 | +7.3% | 0.06% | -5.8% |
| Q2 2019 | $1,317,000 | +327.6% | 30,275 | +382.5% | 0.07% | +263.2% |
| Q3 2018 | $308,000 | +569.6% | 6,275 | +555.7% | 0.02% | +171.4% |
| Q2 2017 | $46,000 | -41.0% | 957 | -60.1% | 0.01% | -56.2% |
| Q4 2016 | $78,000 | -71.1% | 2,401 | -69.6% | 0.02% | -79.7% |
| Q3 2016 | $270,000 | +321.9% | 7,901 | +315.6% | 0.08% | +259.1% |
| Q2 2016 | $64,000 | +3.2% | 1,901 | +137.3% | 0.02% | -47.6% |
| Q4 2015 | $62,000 | – | 801 | +80000.0% | 0.04% | – |
| Q3 2015 | $0 | -100.0% | 1 | -99.8% | 0.00% | -100.0% |
| Q1 2015 | $53,000 | -100.0% | 601 | -82.8% | 0.09% | -66.2% |
| Q3 2014 | $339,317,000 | +47893.9% | 3,501 | -65.3% | 0.26% | -57.4% |
| Q1 2014 | $707,000 | – | 10,100 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |